If you missed out on CDx Europe, Click the image below to explore our 13th World Clinical Biomarkers & CDx Boston Summit
Enabling Precision Medicine in Oncology, CNS & NASH to Power Advanced, Affordable Diagnostics for All
April 26-27, 2023 | London, UK
Accelerating Biomarker-Driven Drugs into Clinical Trials Whilst Strategising Your CDx Development, IVDR Compliance & Commercialisation Path to Improve Clinical Decision Making & Patient Outcomes
The 13th Clinical Biomarkers & CDx Europe 2023 returned as the premier European forum for end-to-end discussions, actionable insights and partnership development to guide biomarker discovery and companion diagnostics (CDx) development programmes as they progress towards commercialisation.
With two dedicated tracks on Biomarker Development and Drug-Dx Development & Commercialisation, this summit was the ultimate guide to:
Understand European Biomarkers & CDx Development advancements in multiple disease areas in oncology and non-oncology indications
Discuss emerging functional assays and software technologies to advance and accelerate clinical and research programs aimed at personalising care for patients
Stay up to date with European specific regulatory, commercialisation and market access challenges and processes to successfully create your end-to-end biomarker & CDx strategy
Join forces to define a better framework for reimbursement of biomarkers that enable an equitable access to them for patients
250+ Clinical Biomarkers, Translational Medicine, Precision Medicine & Companion Diagnostics Directors, Heads and VPs came together with biomarker and CDx solution providers, regulatory experts and notified bodies for a well-rounded, unmissable all-stakeholders included learning and networking experience.
Our 2023 Expert Speaker Faculty Included:
Anna Reznichenko
Senior Director, Team Lead, Translational Science & Experimental Medicine
AstraZeneca
2023 Partners
Other Events in the Series
